PEOPLE - AIMBE elects Minnetronix founder
This article was originally published in Clinica
Executive Summary
Richard Nazarian has been elected as a Fellow at the Washington DC-based American Institute for Medical and Biological Engineering (AIMBE). Mr Nazarian is the founder and former president of Minnetronix, a medical device design company, and has worked in the field for over 20 years. AIMBE represents the field of medical and biological engineering, and attempts to bridge the gap between biological engineering and clinical practice.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.